← Browse by Condition
Medical Condition

brain tumor

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 3, Phase 2, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for brain tumor sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — brain tumor Clinical Trials

How many clinical trials are currently recruiting for brain tumor?
ClinicalMetric currently tracks 15 actively recruiting clinical trials for brain tumor, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 15. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for brain tumor?
brain tumor research spans Phase 1 (2 trials), Phase 2 (3 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a brain tumor clinical trial?
Eligibility criteria for brain tumor trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
3
Phase 3
2
Top Sponsors
Stephen Lownie 1 trial
Jasper Gerritsen 1 trial
Case Comprehensive Cancer Center 1 trial
University of California, San Francisco 1 trial
National Taiwan University Hospital 1 trial

Recruiting Clinical Trials

NCT06229483 Phase 3
Recruiting
The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies
Enrollment
102 pts
Location
Canada
Sponsor
Stephen Lownie
View Trial →
NCT03861299
Recruiting
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
Enrollment
246 pts
Location
Belgium, Netherlands
Sponsor
Jasper Gerritsen
View Trial →
NCT07003542 Phase 2
Recruiting
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Enrollment
48 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent...
View Trial →
NCT07418775
Recruiting
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
Enrollment
3,000 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT05921786
Recruiting
Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling-Establish Reliably Electrophysiological Readouts From Human-induced Pluripotent Stem Cells (hiPSCs)-Derived Cerebral Organoids and Surgically Dissected Human Live Brains
Enrollment
500 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT05588141 Phase 1, Phase 2
Recruiting
000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Enrollment
96 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT04427384
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Enrollment
600 pts
Location
United States
Sponsor
GT Medical Technologies, Inc.
View Trial →
NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Location
United States, Austr...
Sponsor
UMC Utrecht
View Trial →
NCT07381959
Recruiting
Biomarkers of Brain Injury in Children With Brain Tumors
Enrollment
560 pts
Location
Sweden
Sponsor
Uppsala University
View Trial →
NCT06640582 Phase 1, Phase 2
Recruiting
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Enrollment
85 pts
Location
China
Sponsor
Essen Biotech
View Trial →
NCT04706910 Phase 3
Recruiting
18F-DOPA II - PET Imaging Optimization
Enrollment
800 pts
Location
Canada
Sponsor
University of Alberta
View Trial →
NCT06087393
Recruiting
CONVIVO Endomicroscopy
Enrollment
30 pts
Location
United States
Sponsor
Northwell Health
View Trial →
NCT03684109
Recruiting
Non-invasive Glioma Characterization Through Molecular Imaging
Enrollment
30 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT07635329
Recruiting
Home-based Vision Rehabilitation Guided by Brain Imaging
Enrollment
100 pts
Location
United States
Sponsor
Georgetown University
View Trial →
NCT05733312
Recruiting
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
Enrollment
6 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →

Related Conditions

glioblastoma (3) brain cancer (3) meningioma (2) glioma (2) bleeding (1) glioblastoma multiforme (1) glioblastoma multiforme of brain (1) astrocytoma grade iv (1) brain neoplasms (1) meningioma of brain (1) brain diseases (1) cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology